Similar Efficacy in Belatacept-Converted Kidney Transplant Recipients With Steroid-Avoiding Regimen.
Belatacept 轉換的腎臟移植受者在避免類固醇的療法中具有相似的療效。
Kidney Int Rep 2025-04-14
Evaluation of Torque Teno Virus DNA Load as a Predictive Biomarker in Kidney Transplant Recipients Converted from Calcineurin Inhibitors to Belatacept.
轉換自鈣神經酶抑制劑至貝拉班特的腎移植接受者中,鈍角腺病毒DNA量評估作為預測性生物標誌物。
Kidney Int Rep 2024-06-20
Association of early steroid withdrawal with kidney transplant outcomes in first-transplant and retransplant recipients.
首次移植及再移植受者早期類固醇撤回與腎臟移植結果的關聯。
Nephrol Dial Transplant 2024-09-30
Insights from the BKEVER Trial comparing everolimus versus mycophenolate mofetil for BK Polyomavirus infection in kidney transplant recipients.
BKEVER 試驗的見解:比較 everolimus 與 mycophenolate mofetil 在腎臟移植受者中對 BK Polyomavirus 感染的療效。
Kidney Int 2024-11-04
Evaluating the efficacy of basiliximab versus no induction in low-immunological-risk kidney transplant recipients: a propensity score matched analysis.
評估 basiliximab 與無誘導在低免疫風險腎臟移植受者中的療效:一項傾向分數匹配分析。
Ren Fail 2025-02-20
Immunosuppressive treatment patterns in kidney transplant recipients in France: an insurance claims database study (OISTER) over a 12 year period.
法國腎臟移植受贈者的免疫抑制治療模式:為期12年的保險理賠資料庫研究(OISTER)
J Nephrol 2025-05-13